Meridian Bioscience Reports Second Quarter 2020 Operating Results; Raises Guidance on Strength of COVID-19 Related Products
CINCINNATI, May 08, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2020. Second Quarter Fiscal 2020 Highlights: Consolidated Net Revenue of $57.3 million, up 14% year-over-year Life Science segment responded early and swiftly to the COVID-19 pandemic contributing to a record $22.4 million […]